AML (Acute Myeloid Leukemia),Leukemia NPM1 Mutations + Co-Mutations: Decoding the Prognosis Puzzle in AML Dec 18, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Impact of Genomic Alterations on Fixed-Duration Ibr + Ven for CLL Dec 15, 2023
AML (Acute Myeloid Leukemia),Leukemia Iomab-B-Led Regimen Offers New Hope for Elderly AML Patients Dec 04, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Ivosidenib + Azacitidine Improves Outcomes in Newly-Diagnosed AML Nov 30, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Safety and Tolerability of Oral Azacitidine + Venetoclax for AML Nov 30, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Long-Term Efficacy of Venetoclax-Obinutuzumab in CLL Nov 22, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Alliance Phase 3 Study Compares IVO vs Io in Older CLL Patients and Evaluates COVID-19 Impact Nov 20, 2023
